KromaTid GLP Genomic Integrity Karyotyping Services

KromaTid this week introduced its GLP Genomic Integrity Karyotyping services. Developed in collaboration with KromaTiD customers, the new services include a comprehensive analysis of all classes of genomic structural variants with the depth of analysis required to detect the low-frequency events that may occur in cell and gene therapy drug products, the company said. The analysis pipeline begins with unbiased G-band karyotyping based on measurements of both the donor and edited cells, providing information on genomic structural variants related to the editing and cell product expansion process in the same test. KromaTid then provides this data as a variance from the donor cells in its Genomic Integrity Pair-Wise Comparison Report.